Trademark Overview
On Monday, February 3, 2025, a trademark application was filed for QALPHAMIT with the United States Patent and Trademark Office. The USPTO has given the QALPHAMIT trademark a serial number of 99026670. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 3, 2025. This trademark is owned by RayzeBio, Inc.. The QALPHAMIT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.